Paul Bertani
Overview
Explore the profile of Paul Bertani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pan J, Wang X, Chiang C, Ma Y, Cheng J, Bertani P, et al.
Lab Chip
. 2024 Jan;
24(4):819-831.
PMID: 38235543
Localized micro/nano-electroporation (MEP/NEP) shows tremendous potential in cell transfection with high cell viability, precise dose control, and good transfection efficacy. In MEP/NEP, micro or nanochannels are used to tailor the...
2.
Ai Y, Bertani P, Yang H, Lee S, Lu W, Lee J
Mar Pollut Bull
. 2023 Dec;
198:115890.
PMID: 38101057
In cyanotoxin measurements, effective release of intracellular cyanotoxins through cell lysis is pivotal. The conventional method for cell lysis is repeated freeze-thaw (F-T), which has several disadvantages, including poor reproducibility...
3.
Pan J, Chiang C, Wang X, Bertani P, Ma Y, Cheng J, et al.
Nanoscale
. 2023 Feb;
15(8):4080-4089.
PMID: 36744418
Nanochannel electroporation (NEP) is a new technology for cell transfection, which provides superior gene delivery and cell viability to conventional bulk electroporation (BEP). In NEP, the cells laid on a...
4.
Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, et al.
Nat Biomed Eng
. 2021 Jun;
5(8):944-945.
PMID: 34131325
A Correction to this paper has been published: https://doi.org/10.1038/s41551-021-00725-w.
5.
Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, et al.
Nat Biomed Eng
. 2019 Dec;
4(1):69-83.
PMID: 31844155
Exosomes are attractive as nucleic-acid carriers because of their favourable pharmacokinetic and immunological properties and their ability to penetrate physiological barriers that are impermeable to synthetic drug-delivery vehicles. However, inserting...
6.
Gallego-Perez D, Pal D, Ghatak S, Malkoc V, Higuita-Castro N, Gnyawali S, et al.
Nat Nanotechnol
. 2017 Aug;
12(10):974-979.
PMID: 28785092
Although cellular therapies represent a promising strategy for a number of conditions, current approaches face major translational hurdles, including limited cell sources and the need for cumbersome pre-processing steps (for...
7.
Chang L, Gallego-Perez D, Chiang C, Bertani P, Kuang T, Sheng Y, et al.
Small
. 2016 Sep;
12(43):5971-5980.
PMID: 27648733
While electroporation has been widely used as a physical method for gene transfection in vitro and in vivo, its application in gene therapy of cardiovascular cells remains challenging. Due to...
8.
Chang L, Bertani P, Gallego-Perez D, Yang Z, Chen F, Chiang C, et al.
Nanoscale
. 2015 Aug;
8(1):243-52.
PMID: 26309218
Of great interest to modern medicine and biomedical research is the ability to inject individual target cells with the desired genes or drug molecules. Some advances in cell electroporation allow...
9.
Chang L, Gallego-Perez D, Zhao X, Bertani P, Yang Z, Chiang C, et al.
Lab Chip
. 2015 Jun;
15(15):3147-53.
PMID: 26105628
Current transfection technologies lead to significant inter-clonal variations. Previously we introduced a unique electrotransfection technology, Nanochannel-Electroporation (NEP), which can precisely and benignly transfect small cell populations (~100-200 cells) with single-cell...